TrialAnnals of the rheumatic diseases2017

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.

Dae Hyun Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.